STUDY: Discovery of resistance mechanisms to the BRAF inhibitor vemurafenib in metastatic BRAF mutant melanoma

Study Description

Discovery of resistance mechanisms to the BRAF inhibitor vemurafenib in metastatic BRAF mutant melanoma by massively-parallel sequencing of tumour... Show More

Study Accession Alternative Stable ID type
EGAS00001000551 Other

Publications